The finding of a potential relationship between the Fn14 expression and patient outcome in patients undergoing radical prostatectomy for localized PCa [15] points to Fn14 as a novel prognostic biomarker candidate in PCa. This evidence concerns the gene TNFRSF12A and posterior cortical atrophy.